Esther Bernardo, BSc

Platelet Aggregation According to Body Mass Index in Patients Undergoing Coronary Stenting: Should Clopidogrel Loading-Dose Be

08/01/2008

Javier Escaned , MD, PhD;

Manel Sabaté , MD, PhD;

Fernando Alfonso , MD, PhD, FESC;

Antonio Fernandez-Ortiz , MD, PhD;

Esther Bernardo , BSc;

Rosana Hernandez-Antolin , MD, PhD;

Carlos Macaya , MD, PhD;

Carlos Barrera Ramirez , MD;

Dominick J. Angiolillo , MD, PhD;

Cristina Fernandez , MD, PhD;

ABSTRACT: Background. A 300 mg clopidogrel loading-dose (LD) is widely used as an adjunct antithrombotic treatment to reduce the risk of thrombotic events early after coronary stenting (CS). Antithrombotic drugs commonly used during...

ABSTRACT: Background. A 300 mg...

08/01/2008

Journal of Invasive Cardiology

Is a 300 mg Clopidogrel Loading Dose Sufficient to Inhibit
Platelet Function Early After Coronary Stenting? A Platelet
Functio

08/01/2008

Fernando Alfonso , MD, PhD, FESC;

Camino Bañuelos , MD;

Esther Bernardo , BSc;

Rosana Hernandez-Antolin , MD, PhD;

Antonio Fernandez-Ortiz , MD, PhD;

Celia Ramirez , BSc;

Carlos Macaya , MD, PhD;

Javier Escaned , MD, PhD;

Manel Sabaté , MD, PhD;

Raúl Moreno-Gómez , MD, PhD;

Dominick J. Angiolillo , MD, PhD;

ABSTRACT: Background. Clopidogrel combined to aspirin reduces the early risk of stent thrombosis and a clopidogrel pre-treatment strategy is associated with a better outcome. However, in clinical practice such pre-treatment strategy is not...

ABSTRACT: Background....

08/01/2008

Journal of Invasive Cardiology